277 related articles for article (PubMed ID: 15887051)
21. Sentinel lymph node biopsy for melanoma: a critical update for dermatologists after two decades of experience.
Ross MI; Gershenwald JE
Clin Dermatol; 2013; 31(3):298-310. PubMed ID: 23608449
[TBL] [Abstract][Full Text] [Related]
22. Sentinel lymph node biopsy has no benefit for patients with primary cutaneous melanoma metastatic to a lymph node: an assertion based on comprehensive, critical analysis: part I.
Medalie NS; Ackerman AB
Am J Dermatopathol; 2003 Oct; 25(5):399-417. PubMed ID: 14501289
[TBL] [Abstract][Full Text] [Related]
23. Update on the use of sentinel node biopsy in patients with melanoma: who and how.
Chao C; McMasters KM
Curr Opin Oncol; 2002 Mar; 14(2):217-20. PubMed ID: 11880714
[TBL] [Abstract][Full Text] [Related]
24. Sentinel node biopsy versus elective lymph node dissection in patients with cutaneous melanoma in a Japanese population.
Tsutsumida A; Furukawa H; Yamamoto Y; Horiuchi K; Yoshida T; Minakawa H; Fujii S; Murao N; Kuwahara H; Minamimoto T; Fujioka H; Sakamoto T; Honma T
Int J Clin Oncol; 2007 Aug; 12(4):245-9. PubMed ID: 17701001
[TBL] [Abstract][Full Text] [Related]
25. Sentinel lymph node biopsy and melanoma: 2010 update Part I.
Stebbins WG; Garibyan L; Sober AJ
J Am Acad Dermatol; 2010 May; 62(5):723-34; quiz 735-6. PubMed ID: 20398810
[TBL] [Abstract][Full Text] [Related]
26. Analysis of disease free survival in cutaneous melanoma patients subject to sentinel lymph node biopsy.
Łobaziewicz W; Szloch J; Wajda J; Legkiy O; Marczyk E; Wysocki W
Pol Przegl Chir; 2020 Mar; 92(3):15-21. PubMed ID: 32759393
[TBL] [Abstract][Full Text] [Related]
27. Sentinel lymph node biopsy in patients with Stage I/II melanoma: Clinical experience and literature review.
Gipponi M; Di Somma C; Peressini A; Solari N; Gliori S; Nicolo G; Schenone F; Queirolo P; Sertoli MR; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):133-40. PubMed ID: 14991885
[TBL] [Abstract][Full Text] [Related]
28. High positive sentinel node identification rate by EORTC melanoma group protocol. Prognostic indicators of metastatic patterns after sentinel node biopsy in melanoma.
van Akkooi AC; de Wilt JH; Verhoef C; Graveland WJ; van Geel AN; Kliffen M; Eggermont AM
Eur J Cancer; 2006 Feb; 42(3):372-80. PubMed ID: 16403622
[TBL] [Abstract][Full Text] [Related]
29. The impact of immunohistochemistry on sentinel node biopsy for primary cutaneous malignant melanoma.
Ross GL; Shoaib T; Scott J; Camilleri IG; Gray HW; MacKie R; Soutar DS
Br J Plast Surg; 2003 Mar; 56(2):153-5. PubMed ID: 12791361
[TBL] [Abstract][Full Text] [Related]
30. Sentinel node biopsy in malignant melanoma: Swedish experiences 1997-2005.
Mattsson J; Bergkvist L; Abdiu A; Aili Low JF; Naredi P; Ullberg K; Garpered U; Håkansson A; Ingvar C
Acta Oncol; 2008; 47(8):1519-25. PubMed ID: 18941953
[TBL] [Abstract][Full Text] [Related]
31. Pathology of melanocytic lesions: new, controversial, and clinically important issues.
Scolyer RA; Thompson JF; Stretch JR; Sharma R; McCarthy SW
J Surg Oncol; 2004 Jul; 86(4):200-11. PubMed ID: 15221927
[TBL] [Abstract][Full Text] [Related]
32. Sentinel lymph node biopsy in cutaneous melanoma.
Ribero S; Sportoletti Baduel E; Osella-Abate S; Dika E; Quaglino P; Picciotto F; Macripò G; Bataille V
G Ital Dermatol Venereol; 2017 Aug; 152(4):355-359. PubMed ID: 27248147
[TBL] [Abstract][Full Text] [Related]
33. Sentinel lymph node biopsy from the vantage point of an oncologic surgeon.
Wilson LL
Clin Dermatol; 2009; 27(6):594-6. PubMed ID: 19880046
[TBL] [Abstract][Full Text] [Related]
34. Pathologic analysis of sentinel lymph nodes in melanoma patients: current and future trends.
Roberts AA; Cochran AJ
J Surg Oncol; 2004 Mar; 85(3):152-61. PubMed ID: 14991887
[TBL] [Abstract][Full Text] [Related]
35. Sentinel lymph node dissection in primary melanoma reduces subsequent regional lymph node metastasis as well as distant metastasis after nodal involvement.
Leiter U; Buettner PG; Bohnenberger K; Eigentler T; Meier F; Moehrle M; Breuninger H; Garbe C
Ann Surg Oncol; 2010 Jan; 17(1):129-37. PubMed ID: 19866238
[TBL] [Abstract][Full Text] [Related]
36. [Impact of sentinel lymph node biopsy on the treatment of melanoma].
Santinami M; Baldi M; Tragni G; Maurichi A; Moglia D; Bono A; Bartoli C; Patuzzo R; Pennacchioli E; Cascinelli N
Tumori; 2003; 89(4 Suppl):273-5. PubMed ID: 12903619
[TBL] [Abstract][Full Text] [Related]
37. [Cutaneous melanoma and sentinel lymph node biopsy: where are we today?].
Girod A; Salmon R; Rodriguez J
Bull Cancer; 2007 Jul; 94(7):687-91. PubMed ID: 17723951
[TBL] [Abstract][Full Text] [Related]
38. Pathobiology of the sentinel node.
Cochran AJ; Ohsie SJ; Binder SW
Curr Opin Oncol; 2008 Mar; 20(2):190-5. PubMed ID: 18300769
[TBL] [Abstract][Full Text] [Related]
39. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
[TBL] [Abstract][Full Text] [Related]
40. Sentinel lymph node biopsy in cutaneous melanoma: outcome after 5-years follow-up.
Cuchet E; Pinel N; Corcella D; Vuillez JP; Lebeau J; Moutet F; Colonna M; Leccia MT
Eur J Dermatol; 2007; 17(5):387-91. PubMed ID: 17673381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
